rs35659744

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004672.5(MAP3K6):​c.1866C>A​(p.Asn622Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.267 in 1,605,104 control chromosomes in the GnomAD database, including 61,678 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 4302 hom., cov: 33)
Exomes 𝑓: 0.27 ( 57376 hom. )

Consequence

MAP3K6
NM_004672.5 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.183

Publications

41 publications found
Variant links:
Genes affected
MAP3K6 (HGNC:6858): (mitogen-activated protein kinase kinase kinase 6) This gene encodes a serine/threonine protein kinase that forms a component of protein kinase-mediated signal transduction cascades. The encoded kinase participates in the regulation of vascular endothelial growth factor (VEGF) expression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
MAP3K6 Gene-Disease associations (from GenCC):
  • hereditary diffuse gastric adenocarcinoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • gastric cancer
    Inheritance: Unknown Classification: LIMITED Submitted by: Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0039737225).
BP6
Variant 1-27360975-G-T is Benign according to our data. Variant chr1-27360975-G-T is described in ClinVar as Benign. ClinVar VariationId is 403071.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.299 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAP3K6NM_004672.5 linkc.1866C>A p.Asn622Lys missense_variant Exon 14 of 29 ENST00000357582.3 NP_004663.3 O95382-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAP3K6ENST00000357582.3 linkc.1866C>A p.Asn622Lys missense_variant Exon 14 of 29 1 NM_004672.5 ENSP00000350195.2 O95382-1
MAP3K6ENST00000374040.7 linkc.1842C>A p.Asn614Lys missense_variant Exon 13 of 28 1 ENSP00000363152.2 O95382-3
MAP3K6ENST00000493901.6 linkn.1470C>A non_coding_transcript_exon_variant Exon 12 of 27 5
MAP3K6ENST00000671291.1 linkn.700C>A non_coding_transcript_exon_variant Exon 7 of 20

Frequencies

GnomAD3 genomes
AF:
0.211
AC:
32022
AN:
152114
Hom.:
4303
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0578
Gnomad AMI
AF:
0.304
Gnomad AMR
AF:
0.199
Gnomad ASJ
AF:
0.380
Gnomad EAS
AF:
0.0961
Gnomad SAS
AF:
0.147
Gnomad FIN
AF:
0.245
Gnomad MID
AF:
0.320
Gnomad NFE
AF:
0.303
Gnomad OTH
AF:
0.241
GnomAD2 exomes
AF:
0.226
AC:
53166
AN:
235204
AF XY:
0.231
show subpopulations
Gnomad AFR exome
AF:
0.0497
Gnomad AMR exome
AF:
0.140
Gnomad ASJ exome
AF:
0.368
Gnomad EAS exome
AF:
0.0936
Gnomad FIN exome
AF:
0.246
Gnomad NFE exome
AF:
0.303
Gnomad OTH exome
AF:
0.255
GnomAD4 exome
AF:
0.273
AC:
396544
AN:
1452872
Hom.:
57376
Cov.:
52
AF XY:
0.270
AC XY:
195144
AN XY:
721832
show subpopulations
African (AFR)
AF:
0.0494
AC:
1645
AN:
33318
American (AMR)
AF:
0.146
AC:
6458
AN:
44110
Ashkenazi Jewish (ASJ)
AF:
0.370
AC:
9564
AN:
25816
East Asian (EAS)
AF:
0.0981
AC:
3873
AN:
39484
South Asian (SAS)
AF:
0.154
AC:
13111
AN:
85410
European-Finnish (FIN)
AF:
0.245
AC:
12698
AN:
51756
Middle Eastern (MID)
AF:
0.277
AC:
1585
AN:
5720
European-Non Finnish (NFE)
AF:
0.300
AC:
332161
AN:
1107396
Other (OTH)
AF:
0.258
AC:
15449
AN:
59862
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
17072
34144
51215
68287
85359
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10608
21216
31824
42432
53040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.210
AC:
32016
AN:
152232
Hom.:
4302
Cov.:
33
AF XY:
0.207
AC XY:
15426
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.0577
AC:
2399
AN:
41576
American (AMR)
AF:
0.199
AC:
3038
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.380
AC:
1319
AN:
3470
East Asian (EAS)
AF:
0.0955
AC:
493
AN:
5162
South Asian (SAS)
AF:
0.148
AC:
714
AN:
4828
European-Finnish (FIN)
AF:
0.245
AC:
2591
AN:
10596
Middle Eastern (MID)
AF:
0.316
AC:
93
AN:
294
European-Non Finnish (NFE)
AF:
0.303
AC:
20591
AN:
67980
Other (OTH)
AF:
0.237
AC:
501
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1225
2449
3674
4898
6123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
350
700
1050
1400
1750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.261
Hom.:
8966
Bravo
AF:
0.203
TwinsUK
AF:
0.297
AC:
1103
ALSPAC
AF:
0.306
AC:
1178
ESP6500AA
AF:
0.0572
AC:
243
ESP6500EA
AF:
0.296
AC:
2513
ExAC
AF:
0.223
AC:
26852
Asia WGS
AF:
0.0940
AC:
328
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

MAP3K6-related disorder Benign:1
Oct 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
13
DANN
Benign
0.97
DEOGEN2
Benign
0.075
.;T;T
Eigen
Benign
-0.55
Eigen_PC
Benign
-0.61
FATHMM_MKL
Benign
0.032
N
LIST_S2
Benign
0.75
T;.;T
MetaRNN
Benign
0.0040
T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Uncertain
2.3
.;M;M
PhyloP100
0.18
PrimateAI
Benign
0.45
T
PROVEAN
Uncertain
-2.5
D;D;D
REVEL
Benign
0.039
Sift
Benign
0.10
T;T;T
Sift4G
Benign
0.15
T;T;T
Polyphen
0.0030
B;B;B
Vest4
0.043
MutPred
0.35
.;Gain of ubiquitination at N622 (P = 0.0066);Gain of ubiquitination at N622 (P = 0.0066);
MPC
1.2
ClinPred
0.0038
T
GERP RS
-0.34
Varity_R
0.13
gMVP
0.41
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35659744; hg19: chr1-27687466; COSMIC: COSV62887042; COSMIC: COSV62887042; API